Coeptis Therapeutics Holdings (Nasdaq: COEP) and Z Squared Inc. announced a definitive merger agreement on April 25, 2025, to create the world’s largest publicly traded dogecoin-focused mining company. As part of the transaction, Coeptis will spin off its biopharmaceutical operations.

Upon completion of the merger, Z Squared will become a wholly owned subsidiary of Coeptis. In exchange for 9,000 U.S.-based dogecoin (DOGE) mining machines, shareholders of Z Squared will receive equity in Coeptis.

The transaction, approved by both boards of directors, is subject to regulatory clearances, Nasdaq listing compliance, and shareholder approval. Closure is anticipated in Q3 2025, with the combined entity rebranding as Z Squared, Inc. and trading on Nasdaq.

Z Squared executives David Halabu and Michelle Burke will helm the merged company as CEO and COO, respectively. Coeptis CEO Dave Mehalick will step down from the board post-closure. Halabu, founder of Group 10 Capital Management, highlighted the merger's aim to provide investors with concentrated exposure to dogecoin's $27 billion market cap.

The new company will dedicate its efforts to mining dogecoin and collecting proof-of-work blockchain rewards. Mehalick elaborated that shareholders will have the opportunity to participate in dogecoin markets while retaining an interest in the spun-off biopharma operations, which will continue independently.

Coeptis' biopharmaceutical divisions, developing cell therapies for cancer and infectious diseases, will continue operating within the spun-off entity. Its technology division, featuring AI and automation tools, will remain with the merged company.

Z Squared, specializing in the mining of DOGE and litecoin (LTC), aims to capitalize on the burgeoning altcoin mining sector. Further transaction details, including leadership economic interests and merger agreement terms, will be filed with the U.S. Securities and Exchange Commission (SEC).

Investors are directed to relevant filings with the SEC for complete information on leadership economic interests and merger terms.